H
Hugh Hoogendoorn
Researcher at Queen's University
Publications - 11
Citations - 565
Hugh Hoogendoorn is an academic researcher from Queen's University. The author has contributed to research in topics: Thrombin & Von Willebrand factor. The author has an hindex of 9, co-authored 11 publications receiving 552 citations.
Papers
More filters
Journal ArticleDOI
Factor v (quebec): a bleeding diathesis associated with a qualitative platelet factor v deficiency
TL;DR: Platelet Factor V is an essential component in maintaining stable and prolonged hemostasis after trauma and appears to reflect their platelet, rather than their plasma, Factor V activity, according to their bleeding diathesis.
Journal ArticleDOI
Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus
Christoph Male,Denise Foulon,Hugh Hoogendoorn,Patricia Vegh,Earl Silverman,Michèle David,Lesley G. Mitchell +6 more
TL;DR: Positivity for multiple APLA subtypes showed stronger associations with TEs than for individual APLASubtypes because of improved specificity, and Lupus anticoagulant is the strongest predictor of the risk of TEs.
Journal ArticleDOI
The fibrinolytic potential of the normal primate following the generation of thrombin in vivo.
Alan R. Giles,Michael E. Nesheim,Steven W Herring,Hugh Hoogendoorn,David C. Stump,Charles M Heldebrant +5 more
TL;DR: Parameters of the fibrinolytic system were studied in a primate model where the generation of thrombin was promoted in vivo and an associated activation of protein C and increased fibralelytic activity was demonstrated.
Journal ArticleDOI
Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
M F Scully,Cheng Hock Toh,Hugh Hoogendoorn,Reginald P. Manuel,Michael E. Nesheim,S Solymoss,Alan R. Giles +6 more
TL;DR: Findings in an experimental animal model of DIC suggested that alpha 2-macroglobulin and alpha 1-antitrypsin become more important inhibitors of APC as the primary inhibitor PCI is consumed in the face of a sustained procoagulant challenge.
Journal ArticleDOI
Type IIB von Willebrand's disease presenting as thrombocytopenia during pregnancy.
TL;DR: Type IIb von Willebrand's disease should be considered in the differential diagnosis of thrombocytopenia developing during pregnancy, particularly in those individuals where evidence supporting the diagnosis of immune mediated thromBocy topenia is not forthcoming.